Doxorubicin Hcl

Role

Indications

Reactions

Primary

Diffuse Large B-cell Lymphoma	18.1%
Prophylaxis	10.9%
Hodgkin's Disease	9.5%
Breast Cancer	8.1%
Non-hodgkin's Lymphoma	7.0%
Multiple Myeloma	6.6%
Ovarian Cancer Recurrent	5.8%
Product Used For Unknown Indication	4.9%
Acute Lymphocytic Leukaemia	4.3%
Burkitt's Lymphoma	4.0%
B-cell Lymphoma	3.7%
Lymphoma	3.2%
Ovarian Cancer	2.8%
Mantle Cell Lymphoma	2.0%
Breast Cancer Metastatic	1.7%
Constipation	1.7%
Chronic Lymphocytic Leukaemia	1.5%
Sarcoma	1.5%
Bone Sarcoma	1.4%
Stomatitis	1.3%

Interstitial Lung Disease	8.6%
Pneumocystis Jiroveci Pneumonia	7.4%
Off Label Use	7.3%
Death	6.7%
Vomiting	6.7%
White Blood Cell Count Decreased	6.7%
Neutropenia	5.8%
Pyrexia	5.4%
Sepsis	5.3%
Ovarian Cancer	4.9%
Pneumonia	4.7%
Febrile Neutropenia	4.4%
Palmar-plantar Erythrodysaesthesia Syndrome	4.3%
Stomatitis	3.8%
Pulmonary Toxicity	3.6%
Renal Failure	3.1%
Hepatitis B	3.0%
Thrombocytopenia	2.9%
Myocardial Infarction	2.7%
Infection	2.6%

Secondary

Diffuse Large B-cell Lymphoma	26.1%
Drug Use For Unknown Indication	11.4%
Breast Cancer	7.8%
Prophylaxis	7.0%
Product Used For Unknown Indication	6.3%
Non-hodgkin's Lymphoma	5.9%
B-cell Lymphoma	5.5%
Hodgkin's Disease	4.8%
Multiple Myeloma	4.3%
Mantle Cell Lymphoma	3.1%
Ovarian Cancer Recurrent	2.9%
Burkitt's Lymphoma	2.9%
Acute Lymphocytic Leukaemia	2.5%
Lymphoma	2.4%
T-cell Lymphoma	1.7%
Constipation	1.3%
Peripheral T-cell Lymphoma Unspecified	1.3%
Stomatitis	1.1%
Sarcoma	0.9%
Hypertension	0.9%

Febrile Neutropenia	16.4%
Neutropenia	8.3%
White Blood Cell Count Decreased	7.0%
Pyrexia	6.8%
Vomiting	6.2%
Sepsis	5.6%
Death	4.4%
Thrombocytopenia	4.1%
Pneumonia	4.1%
Off Label Use	4.0%
Interstitial Lung Disease	3.8%
Pneumocystis Jiroveci Pneumonia	3.8%
Pulmonary Embolism	3.7%
Palmar-plantar Erythrodysaesthesia Syndrome	3.7%
Septic Shock	3.6%
Infection	3.3%
Stomatitis	3.2%
Myelodysplastic Syndrome	2.8%
Ovarian Cancer Recurrent	2.7%
Acute Myeloid Leukaemia	2.3%

Concomitant

Drug Use For Unknown Indication	17.6%
Diffuse Large B-cell Lymphoma	13.4%
Breast Cancer	8.9%
Non-hodgkin's Lymphoma	8.7%
B-cell Lymphoma	8.3%
Product Used For Unknown Indication	6.2%
Lymphoma	5.4%
Chemotherapy	5.0%
Multiple Myeloma	4.7%
Prophylaxis	4.1%
Acute Lymphocytic Leukaemia	3.2%
Hiv Infection	2.5%
Hodgkin's Disease	2.3%
Mantle Cell Lymphoma	1.8%
Chronic Lymphocytic Leukaemia	1.7%
T-cell Lymphoma	1.5%
Burkitt's Lymphoma	1.4%
Breast Cancer Metastatic	1.1%
Pain	1.1%
Hypertension	1.0%

Febrile Neutropenia	12.0%
Progressive Multifocal Leukoencephalopathy	9.6%
Neutropenia	7.3%
Vomiting	6.8%
Pneumocystis Jiroveci Pneumonia	6.1%
Thrombocytopenia	5.7%
Pyrexia	5.1%
Sepsis	5.1%
Respiratory Failure	4.7%
Death	4.6%
White Blood Cell Count Decreased	4.4%
Septic Shock	4.0%
Renal Failure Acute	3.6%
Weight Decreased	3.5%
Renal Failure	3.3%
Hepatitis B	3.2%
Interstitial Lung Disease	2.8%
Pancytopenia	2.8%
White Blood Cell Count Increased	2.8%
Drug Ineffective	2.6%

Interacting

Non-hodgkin's Lymphoma	22.0%
Non-hodgkin's Lymphoma Unspecified Histology Aggressive	14.6%
Product Used For Unknown Indication	9.8%
Drug Use For Unknown Indication	8.1%
Diffuse Large B-cell Lymphoma	6.5%
Hodgkin's Disease	6.5%
Bone Sarcoma	4.9%
Breast Cancer	4.1%
Lymphoma	4.1%
Breast Cancer Metastatic	3.3%
Prophylaxis Of Nausea And Vomiting	3.3%
Delirium	2.4%
Bone Pain	1.6%
Histoplasmosis	1.6%
Hormone Therapy	1.6%
Neoplasm Malignant	1.6%
Prophylaxis	1.6%
Acne	0.8%
Acute Lymphocytic Leukaemia	0.8%
Arthralgia	0.8%